Kenya BioVax Institute Limited held a site visit and partnership meeting with Kenya Veterinary Vaccines Production Institute – KEVEVAPI to explore vaccine production and innovation synergies. The discussions highlighted the importance of adhering to Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLPs) as key pillars for ensuring the safety and efficacy of vaccines.
Members were also taken through the regulatory and quality assurance frameworks that shape the vaccine manufacturing environment. Both organizations emphasized the need to enhance biosafety and biosecurity measures to safeguard operations, employees, and the environment while maintaining high-quality standards in vaccine production. By aligning processes with global best practices, the two institutions aim to create robust systems that ensure product integrity and build stakeholder trust.
A key highlight of the discussions was integrating the One Health approach, which underscores the interconnection between human, animal, and environmental health. Kenya BioVax Institute and KEVEVAPI identified shared opportunities for joint research, capacity building, and cross-sectoral initiatives to promote health security. This collaboration represents a significant step forward in advancing veterinary and human health solutions, reinforcing the commitment of both organizations to drive impactful and sustainable change.